APA (7th ed.) Citation

SMH, E., AJ, B., H, Z., AS, F., CP, D., MC, M., . . . LS, M. (2022). Multicenter evaluation of neoadjuvant and induction gemcitabine-carboplatin versus gemcitabine-cisplatin followed by radical cystectomy for muscle-invasive bladder cancer. World journal of urology, 40(11), 2707. https://doi.org/10.1007/s00345-022-04160-7

Chicago Style (17th ed.) Citation

SMH, Einerhand, et al. "Multicenter Evaluation of Neoadjuvant and Induction Gemcitabine-carboplatin Versus Gemcitabine-cisplatin Followed by Radical Cystectomy for Muscle-invasive Bladder Cancer." World Journal of Urology 40, no. 11 (2022): 2707. https://doi.org/10.1007/s00345-022-04160-7.

MLA (9th ed.) Citation

SMH, Einerhand, et al. "Multicenter Evaluation of Neoadjuvant and Induction Gemcitabine-carboplatin Versus Gemcitabine-cisplatin Followed by Radical Cystectomy for Muscle-invasive Bladder Cancer." World Journal of Urology, vol. 40, no. 11, 2022, p. 2707, https://doi.org/10.1007/s00345-022-04160-7.